In This Section

Denise Adams, MD
Denise Adams
Director of the Comprehensive Vascular Anomalies Program

Dr. Adams is director of the Comprehensive Vascular Anomalies Program, a cutting-edge, multidisciplinary program that seeks breakthrough treatments and cures for children, adolescents, and young adults with rare, life-threatening tumors and malformations. 

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

6 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Bio

Dr. Adams is director of the Comprehensive Vascular Anomalies Program (CVAP), a cutting-edge, multidisciplinary program that seeks breakthrough treatments and cures for children, adolescents, and young adults with rare, life-threatening tumors and malformations, which includes the arteries, veins, capillaries, lymphatics, and combined lesions. 

As a prominent pediatric hematologist-oncologist and leading expert in the field, Dr. Adams is actively engaged in clinical and translational research on complex vascular anomalies and regularly publishes studies in leading journals on the topic. She has received numerous awards, for her teaching and mentorship and for her research and clinical accomplishments. Hospitals, universities, and conferences around the world have invited her to speak on the topic of vascular anomalies, recognizing her expertise in this area.

Education and Training

MD, Georgetown University School of Medicine (Medicine)

Intern, Medical Center Hospital of Vermont/ University of Vermont (Obstetrics/Gynecology)

Intern, Medical Center Hospital of Vermont/ University of Vermont (Pediatrics)

Resident, Medical Center Hospital of Vermont/ University of Vermont (Pediatrics)

Clinical Fellow, Duke University Medical Center (Pediatric Hematology/Oncology)

Titles and Academic Titles

Co-Director of the Comprehensive Vascular Anomalies Program

Pediatric Hematologist-Oncologist

Professional Memberships

Children's Oncology Group (COG), 1996-

International Society for the Study of Vascular Anomalies (ISSVA) , 1998-

International Society for the Study of Vascular Anomalies (ISSVA), Treasurer, 2006 -

Hemangioma Investigator Group (HIG), 2008-

American Society of Clinical Oncology (ASCO), 1996-

American Society of Hematology (ASH), 1996-

American Society of Pediatric Hematology/Oncology (ASPHO), 2006-

National Organization of Vascular Anomalies (NOVA), 1998-

Lymphangiomatosis and Gorham's Disease Alliance (LGDA), 2003-

Klippel-Trenauney (K-T) Support Group, 2006-

American Academy of Pediatrics (AAP), 2011-

Professional Awards

Best Doctor - Cincy Magazine, 2009-2016

Fellow, Executive Leadership in Academic Medicine, Drexel University College of Medicine, 2015-2016

Endowed Chair in Vascular Anomalies, Boston Children's Hospital, 2016

Best Doctors - Boston Magazine, 2016-2020

Inaugural George Buchanan Lectureship Award, American Society of Pediatric Hematology Oncology, 2016